壳聚糖药用制剂及其应用的研究进展  

Research progress of application of pharmaceutical preparation chitosan

作　　者：邹兴龙 陈柱先 孙娟娟 蔡江滢 苏露[1] 马薇[1] 傅思武[1] ZOU Xing-long;CHEN Zhu-xian;SUN Juan-juan;CAI Jiang-ying;SU Lu;MA Wei;FU Si-wu(Department of Medicine,Northwest Minzu University,Lanzhou 730030,China)

机构地区：[1]西北民族大学医学部,甘肃兰州730030

出　　处：《基础医学与临床》2022年第11期1791-1794,共4页Basic and Clinical Medicine

基　　金：西北民族大学2020年本科生科研能力训练项目(XBMU-BYL20213);中央高校基本科研业务费创新团队项目(31920200001)。

摘　　要：壳聚糖(CTS)作为自然界中唯一的碱性多糖,具有独特的生理活性、良好的成膜性、吸附性及抗菌性等特性。CTS及其衍生物的各种药用制剂和临床应用,证明了CTS产品在医药制剂领域的实用性,CTS及其衍生物在医药领域及临床应用中具有良好的发展前景。As the only alkaline polysaccharide in nature,chitosan(CTS)is haracterized by its unique physiological activity,good film-forming capacity,well adsorption and antibacterial properties.Various pharmaceutical preparations and clinical applications of CTS and its derivatives have proved the practicability of CTS products in the field of pharmaceutical preparations.CTS and its derivatives have a good development prospect in the field of medicine and clinical application.

关 键 词：壳聚糖 药用制剂 药物载体 临床应用 

分 类 号：Q539[生物学—生物化学]